Lion Biotechnologies Inc
Lion Biotechnologies Inc operates in various business sectors.
Lion Biotechnologies Inc (2LB) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.128x
Based on the latest financial reports, Lion Biotechnologies Inc (2LB) has a cash flow conversion efficiency ratio of -0.128x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-98.43 Million) by net assets (€768.54 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Lion Biotechnologies Inc - Cash Flow Conversion Efficiency Trend (2018–2023)
This chart illustrates how Lion Biotechnologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Lion Biotechnologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Lion Biotechnologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Equals Group PLC
LSE:EQLS
|
0.121x |
|
Brinno Incorporated
TWO:7402
|
N/A |
|
RED ROBIN GRMT BURG
BE:RRN
|
0.233x |
|
BONTERRA ENERGY (QNC1.SG)
STU:QNC1
|
0.058x |
|
IMPREGILO
BE:IPJ1
|
N/A |
|
208850
KO:208850
|
N/A |
|
Beeio Honey Ltd
TA:BHNY
|
-0.172x |
|
Chokwang Paint Co. Ltd.
KQ:004910
|
N/A |
Annual Cash Flow Conversion Efficiency for Lion Biotechnologies Inc (2018–2023)
The table below shows the annual cash flow conversion efficiency of Lion Biotechnologies Inc from 2018 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | €584.61 Million | €-361.82 Million | -0.619x | -5.63% |
| 2022-12-31 | €499.64 Million | €-292.76 Million | -0.586x | -59.80% |
| 2021-12-31 | €621.66 Million | €-227.94 Million | -0.367x | -17.35% |
| 2020-12-31 | €656.50 Million | €-205.13 Million | -0.312x | +52.80% |
| 2019-12-31 | €298.97 Million | €-197.93 Million | -0.662x | -204.83% |
| 2018-12-31 | €466.19 Million | €-101.25 Million | -0.217x | -- |